Read More Pharma Industry News Legend Biotech announces submission of CARVYKTI application to EMA for multiple myeloma Legend Biotech has announced the submission of a Type II variation application to the European Medicines Agency (EMA)… byPallavi MadhirajuMay 28, 2023